Drugs / FTC 200 mg/TDF 300 mg FDC tablet administered orally once daily
FTC 200 mg/TDF 300 mg FDC tablet administered orally once daily
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01565850 | Apr 2012 → Jan 2013 | AIDS | Gilead Sciences | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FTC 200 mg/TDF 300 mg FDC tablet administered orally once daily | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01565850 ↗ |
| Route | Oral | “FTC 200 mg/TDF 300 mg FDC tablet administered orally once daily” NCT01565850 ↗ |